Frequently mutated in about half of all human cancers and functionally inactivated through non-genomic mechanisms in the remaining malignancies, the tumor suppressor p53 is not mutated in TGCTs, and is activated following exposure to chemotherapeutic agents, both events that have implications for the chemosensitivity of these tumors [96, 97]. Here, TP53 is linked to cancer.